LB Pharmaceuticals Inc (LBRX)
NASDAQ: LBRX · Real-Time Price · USD
30.90
-0.51 (-1.62%)
Jul 20, 2026, 4:00 PM EDT - Market closed
LB Pharmaceuticals Market Cap
LB Pharmaceuticals has a market cap or net worth of $886.11 million as of July 20, 2026.
Market Cap
886.11M
Enterprise Value
523.94M
1-Year Change
n/a
Ranking
Category
Stock Price
$30.90
ChartMarket Cap Chart
Since the IPO on September 11, 2025, LB Pharmaceuticals's market cap has increased from $301.50M to $886.11M, an increase of 193.90%. That is a compound annual growth rate of 252.96%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 20, 2026 | 886.11M | 57.35% |
| Dec 31, 2025 | 563.16M | 86.78% |
| Sep 11, 2025 | 301.50M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Annexon | 950.29M |
| Sana Biotechnology | 944.68M |
| Pharming Group | 926.15M |
| Geron | 923.79M |
| Arbutus Biopharma | 900.77M |
| DBV Technologies | 880.40M |
| Theravance Biopharma | 877.45M |
| Phathom Pharmaceuticals | 868.97M |